Medtronic Inc.'s Symplicity system, designed to treat high blood pressure in patients, took a blow last year when it flubbed a clinical trial. But the company is poised to launch another trial this year.
Forbes, citing securities filings, reports that Fridley-based Medtronic will soon ask the Food and Drug Administration for permission to launch a phase II trial. Rival Boston Scientific, which has its own hypertension-device treatment in the works, also plans to launch a clinical trial.
Help employers find you! Check out all the jobs and post your resume.
